More than 250 million people are living with chronic hepatitis B despite the availability of
highly effective vaccines and oral antivirals. Although innate and adaptive immune cells play …

Hepatitis B virus (HBV) infection, although preventable by vaccination, remains a global
health problem and a major cause of chronic liver disease. Although current treatment …

Background The role of M0 macrophages and their related genes in the prognosis of
hepatocellular carcinoma (HCC) remains poorly characterized. Methods Multidimensional …

Chronic hepatitis B (CHB) infection remains a serious public health problem worldwide;
however, the relationship between cholesterol levels and CHB remains unclear. We isolated …

Hepatitis B virus (HBV) infection is a global public health problem that is closely related to
liver cirrhosis and hepatocellular carcinoma (HCC). The prevalence of acute and chronic …

Epigenetic modification occurring in RNA has become the hotspot of the field. N 6-
methyladenosine (m6A) methylation is the most abundant RNA internal modification mainly …

Myeloid derived suppressor cells (MDSCs) are a heterogenous population of myeloid cells
derived from monocyte and granulocyte precursors. They are pathologically expanded in …

Chronic hepatitis B virus (HBV) infection is an international health problem with extremely
high mortality and morbidity rates. Although current clinical chronic hepatitis B (CHB) …

Globally, hepatitis B virus (HBV) infection and its related liver diseases account for 780,000
deaths every year. Outcomes of HBV infection depend on the interaction between the virus …

ABSTRACT Introduction Chronic hepatitis B (CHB) is rarely cured using available
treatments. Barriers to cure are: 1) persistence of reservoirs of hepatitis B virus (HBV) …